Cardiovascular disease in diabetes, beyond glucose

被引:134
作者
Eckel, Robert H. [1 ,2 ]
Bornfeldt, Karin E. [3 ,4 ]
Goldberg, Ira J. [5 ]
机构
[1] Univ Colorado, Div Endocrinol Metab & Diabet, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Colorado, Div Cardiol, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
[4] Univ Washington, Dept Lab Med & Pathol, Med Diabet Inst, Seattle, WA 98195 USA
[5] NYU, Div Endocrinol Diabet & Metab, Grossman Sch Med, New York, NY USA
关键词
CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; PRESSURE-LOWERING TREATMENT; INTENSIVE GLYCEMIC CONTROL; IMPAIRED FASTING GLUCOSE; SYSTOLIC BLOOD-PRESSURE; ALL-CAUSE MORTALITY; 10-YEAR FOLLOW-UP; INSULIN-RESISTANCE; RISK-FACTORS;
D O I
10.1016/j.cmet.2021.07.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Despite the decades-old knowledge that diabetes mellitus is a major risk factor for cardiovascular disease, the reasons for this association are only partially understood. While this association is true for both type 1 and type 2 diabetes, different pathophysiological processes may be responsible. Lipids and other risk factors are indeed important, whereas the role of glucose is less clear. This lack of clarity stems from clinical trials that do not unambiguously show that intensive glycemic control reduces cardiovascular events. Animal models have provided mechanisms that link diabetes to increased atherosclerosis, and evidence consistent with the importance of factors beyond hyperglycemia has emerged. We review clinical, pathological, and animal studies exploring the pathogenesis of atherosclerosis in humans living with diabetes and in mouse models of diabetes. An increased effort to identify risk factors beyond glucose is now needed to prevent the increased cardiovascular disease risk associated with diabetes.
引用
收藏
页码:1519 / 1545
页数:27
相关论文
共 319 条
[1]   Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].
Adler, AI ;
Stratton, IM ;
Neil, HAW ;
Yudkin, JS ;
Matthews, DR ;
Cull, CA ;
Wright, AD ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419
[2]   Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States [J].
Aguayo-Mazzucato, Cristina ;
Diaque, Paula ;
Hernandez, Sonia ;
Rosas, Silvia ;
Kostic, Aleksandar ;
Caballero, Augusto Enrique .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (02)
[3]   Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs [J].
Al-Mashhadi, Rozh H. ;
Bjorklund, Martin M. ;
Mortensen, Martin B. ;
Christoffersen, Christina ;
Larsen, Torben ;
Falk, Erling ;
Bentzon, Jacob F. .
DIABETOLOGIA, 2015, 58 (08) :1926-1936
[4]   Relationships of Obesity and Fat Distribution With Atherothrombotic Risk Factors: Baseline Results From the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial [J].
Albu, Jeanine B. ;
Lu, Jiang ;
Mooradian, Arshag D. ;
Krone, Ronald J. ;
Nesto, Richard W. ;
Porter, Marty H. ;
Rana, Jamal S. ;
Rogers, William J. ;
Sobel, Burton E. ;
Gottlieb, Sheldon H. .
OBESITY, 2010, 18 (05) :1046-1054
[5]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[6]   Inflammation, adiposity, and progression of arterial stiffness in adolescents with type 1 diabetes: The SEARCH CVD Study [J].
Alman, Amy C. ;
Talton, Jennifer W. ;
Wadwa, R. Paul ;
Urbina, Elaine M. ;
Dolan, Lawrence M. ;
Hamman, Richard F. ;
D'Agostino, Ralph B., Jr. ;
Marcovina, Santica M. ;
Dabelea, Dana M. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (11) :995-999
[7]  
American Diabetes Association, 2021, DIABETES CARE, V44, pS4
[8]   Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity [J].
Aminian, Ali ;
Zajichek, Alexander ;
Arterburn, David E. ;
Wolski, Kathy E. ;
Brethauer, Stacy A. ;
Schauer, Philip R. ;
Kattan, Michael W. ;
Nissen, Steven E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (13) :1271-1282
[9]  
Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000677, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]
[10]   S100A8 and S100A9 in Cardiovascular Biology and Disease [J].
Averill, Michelle M. ;
Kerkhoff, Claus ;
Bornfeldt, Karin E. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (02) :223-229